Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pollard

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Molecular Biology of the Cell|May 19, 2021
Disruption of a ∼23-24 nucleotide small RNA pathway elevates DNA damage responses in <i>Tetrahymena thermophila</i>Suzanne R Lee, Daniel A Pollard, Domenico F Galati, et al.
Frontiers in Cardiovascular Medicine|July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group reportKasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.
Blood Advances|October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 reportLisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer|October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances|January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemiaKatherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
BMJ Open|July 8, 2015
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary diseaseAnnabel H Nickol, Matthew C Frise, Hung-Yuan Cheng, et al.
The New England Journal of Medicine|November 24, 2021
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang SyndromeJunne Kamihara, Kayla V Hamilton, Jessica A Pollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
Plos Biology|February 15, 2008
Transcription factors bind thousands of active and inactive regions in the Drosophila blastodermXiao-yong Li, Stewart MacArthur, Richard Bourgon, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Molecular Biology of the Cell|May 19, 2021
Disruption of a ∼23-24 nucleotide small RNA pathway elevates DNA damage responses in <i>Tetrahymena thermophila</i>Suzanne R Lee, Daniel A Pollard, Domenico F Galati, et al.
Frontiers in Cardiovascular Medicine|July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group reportKasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.
Blood Advances|October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 reportLisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer|October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances|January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemiaKatherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
BMJ Open|July 8, 2015
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary diseaseAnnabel H Nickol, Matthew C Frise, Hung-Yuan Cheng, et al.
The New England Journal of Medicine|November 24, 2021
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang SyndromeJunne Kamihara, Kayla V Hamilton, Jessica A Pollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid LeukemiaTamara P Miller, Yimei Li, Marko Kavcic, et al.
Plos Biology|February 15, 2008
Transcription factors bind thousands of active and inactive regions in the Drosophila blastodermXiao-yong Li, Stewart MacArthur, Richard Bourgon, et al.
Pageof 32